Sapient: Funding, Investors & Team (Sep 2026)
Insightful empowers the revelation of flowing biomarkers at remarkable speed and scale. Their foundation joins progressed mass spectrometry innovations, computational learning, and the world's biggest exclusive human compound information base to convey significant bits of knowledge that speed up drug creation. Their strategies decrease the time and intricacy of biomarker revelation at any stage, helping supports select and upgrade the best medication possibility for clinical headway.
Sapient has raised $9.2M across 1 funding round on record, the most recent a Grant of $9.2M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sapient Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Sapient Funding Rounds
Sapient Founders and Leadership Team
Contact details for the Sapient team: 1 of 1 has an email address on file.
Start 14-day free trial →Sapient Funding Compared to Other Biotechnology Startups
Sapient's latest round of $9.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sapient in Biotechnology and San Diego
Companies Similar to Sapient
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Sapient Funding FAQs
What does Sapient do?
Insightful empowers the revelation of flowing biomarkers at remarkable speed and scale. Their foundation joins progressed mass spectrometry innovations, computational learning, and the world's biggest exclusive human compound information base to convey significant bits of knowledge that speed up drug creation. Their strategies decrease the time and intricacy of biomarker revelation at any stage, helping supports select and upgrade the best medication possibility for clinical headway.
How much funding has Sapient raised?
Sapient has raised $9.2M across 1 round on record. The most recent is a Grant of $9.2M announced in Jul 2022.
When did Sapient last raise funding?
Sapient's most recent funding round on record is a Grant of $9.2M, announced in Jul 2022.
Who founded Sapient?
FundedIQ lists Saumya Tiwari (Founder) at Sapient.
Where is Sapient headquartered?
Sapient is based in San Diego, California, United States.
How many employees does Sapient have?
Sapient is in the 11-50 employee band.
How does Sapient's funding compare to other Biotechnology startups?
Sapient's latest round of $9.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Sapient Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sapient is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.